These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34687271)

  • 1. Repetitive short-pulsed illumination efficiently activates photoactivatable-Cre as continuous illumination in embryonic stem cells and pre-implantation embryos of transgenic mouse.
    Kishi K; Koyama H; Oka S; Kato A; Sato M; Fujimori T
    Genesis; 2021 Dec; 59(12):e23457. PubMed ID: 34687271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A photoactivatable Cre-loxP recombination system for optogenetic genome engineering.
    Kawano F; Okazaki R; Yazawa M; Sato M
    Nat Chem Biol; 2016 Dec; 12(12):1059-1064. PubMed ID: 27723747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoactivatable Cre recombinase 3.0 for in vivo mouse applications.
    Morikawa K; Furuhashi K; de Sena-Tomas C; Garcia-Garcia AL; Bekdash R; Klein AD; Gallerani N; Yamamoto HE; Park SE; Collins GS; Kawano F; Sato M; Lin CS; Targoff KL; Au E; Salling MC; Yazawa M
    Nat Commun; 2020 May; 11(1):2141. PubMed ID: 32358538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a tTA-dependent photoactivatable Cre recombinase knock-in mouse model for optogenetic genome engineering.
    Takao T; Hiraoka Y; Kawabe K; Yamada D; Ming L; Tanaka K; Sato M; Takarada T
    Biochem Biophys Res Commun; 2020 May; 526(1):213-217. PubMed ID: 32204914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoactivatable Cre knock-in mice for spatiotemporal control of genetic engineering in vivo.
    Yoshimi K; Yamauchi Y; Tanaka T; Shimada T; Sato M; Mashimo T
    Lab Invest; 2021 Jan; 101(1):125-135. PubMed ID: 32892213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse opsin promoter-directed Cre recombinase expression in transgenic mice.
    Le YZ; Zheng L; Zheng W; Ash JD; Agbaga MP; Zhu M; Anderson RE
    Mol Vis; 2006 Apr; 12():389-98. PubMed ID: 16636658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable Transgenic Mouse Strain with Enhanced Photoactivatable Cre Recombinase for Spatiotemporal Genome Manipulation.
    Li H; Wu Y; Qiu Y; Li X; Guan Y; Cao X; Liu M; Zhang D; Huang S; Lin L; Hui L; Ma X; Liu M; Zhang X; Wang L; Li D
    Adv Sci (Weinh); 2022 Dec; 9(34):e2201352. PubMed ID: 36266974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination.
    Betz UA; Vosshenrich CA; Rajewsky K; Müller W
    Curr Biol; 1996 Oct; 6(10):1307-16. PubMed ID: 8939573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-invasive far-red light-induced split-Cre recombinase system for controllable genome engineering in mice.
    Wu J; Wang M; Yang X; Yi C; Jiang J; Yu Y; Ye H
    Nat Commun; 2020 Jul; 11(1):3708. PubMed ID: 32709899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pou4f2 knock-in Cre mouse: A multifaceted genetic tool for vision researchers.
    Simmons AB; Bloomsburg SJ; Billingslea SA; Merrill MM; Li S; Thomas MW; Fuerst PG
    Mol Vis; 2016; 22():705-17. PubMed ID: 27390513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
    Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
    Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Manipulating Living Systems by Light].
    Sato M
    Yakugaku Zasshi; 2020; 140(8):993-1000. PubMed ID: 32741873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cell-specific Cre/loxP-mediated recombination in vivo.
    Scholten J; Hartmann K; Gerbaulet A; Krieg T; Müller W; Testa G; Roers A
    Transgenic Res; 2008 Apr; 17(2):307-15. PubMed ID: 17972156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
    Hayashi S; McMahon AP
    Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter.
    St-Onge L; Furth PA; Gruss P
    Nucleic Acids Res; 1996 Oct; 24(19):3875-7. PubMed ID: 8871571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line.
    Lewandoski M; Wassarman KM; Martin GR
    Curr Biol; 1997 Feb; 7(2):148-51. PubMed ID: 9016703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.